A Few Thoughts on Manhattan's World Cup Finale
A disappointing match but a phenomenal World Cup
I spent the past three days in New York City, my first trip there in nearly a year thanks to family life obligations, co-hosting the Big Weekend Show on Fox News — where I had the privilege of teaching my co-hosts about this thing called soccer in one of my more cosmopolitan moments in years.
After offering commentary on the result for three hours, the contrast of Times Square the night before — full of excited Argentina fans — with the relative calm of Sunday night was almost eerie. I’d offer my sympathies, but Spain so clearly deserved the win that would be disingenuous. Don’t cry for Messi, he’ll be fine.
It was also strange to be back in Manhattan having a sliding door view of the pre and post-Mamdani city: everything was worse, particularly the amount of evident vagrancy and street level drug use. Before I left, an anti-ICE lunatic set off a firebomb in front their federal building. No wonder the mayor’s trying to distract people with the prospect of arresting Bibi Netanyahu.
What is stunning about the weekend is that it brings to a close a phenomenally successful World Cup — one that was fraught with early concerns about infrastructure, security, transportation, and the basic confusion inherent in the arrival of hundreds of thousands of foreign tourists. Some Democrats openly hoped for a massive failure under the Trump Administration. Instead they were left complaining about the reflecting pool, because everything that could go wrong instead went right.
Don’t expect the administration to get any credit for this, of course. But it’s impressive to see that when America puts its effort behind pulling off a grand show for the world, it can still rise to the occasion.
A Doctor’s View on Aldous Huxley and GLP-1s
Every shift I’ve worked in the emergency department, I’ve seen the downstream consequences of America’s obesity epidemic. I see the 52-year-old father having a massive heart attack, or the diabetic foot infection that ends in an amputation, or the stroke that steals someone’s ability to speak to their loved ones, or the dialysis patient whose life is scheduled around a machine three days a week. By the time obesity reaches my emergency department, it’s no longer about vanity; it’s about people’s lives permanently changing or even prematurely ending.
For decades, physicians had few effective tools beyond telling patients to eat less and exercise more, a prescription that is technically correct but woefully inadequate against a food environment engineered to maximize consumption.
GLP-1’s have flipped that entire conversation on its head. For millions of Americans living with obesity and diabetes, these drugs have been transformative. Patients who spent years cycling through diets and medications are finally losing meaningful weight, improving their blood sugar, lowering their cardiovascular risk, and reclaiming their health. But as remarkable as the clinical results around GLP-1s have been, people still tend to misunderstand how and why they work.
Most Americans think of GLP-1s as appetite suppressants. You get full after one slice of pizza instead of two, so you lose weight, but that’s only half of the story. GLP-1 receptors are found not only throughout the digestive tract, but also in many regions of the brain involved in appetite and reward; they block the ability of your brain to anticipate and perceive pleasure from food, among other things.
This is something wholly different than suppressing hunger. This is no longer about weight loss so much as it is something entirely more personal: motivation. That second slice of pizza may still taste good, but you just don’t want it now. That is not a drug acting solely on the gut. It is a drug acting on the mind.
The implications of this are gobsmacking and reach well beyond obesity. Early studies suggest similar effects on alcohol, gambling, and other compulsive behaviors. For the first time, medicine isn’t simply treating disease; it’s beginning to change the motivational systems that drive human behavior. And that possibility forces us to ask a much bigger question.
In the dystopian novel Brave New World, Aldous Huxley wrote of a society that sought to eliminate suffering through chemistry and genetic engineering. Citizens took a drug called soma, which didn’t cure disease so much as silence dissatisfaction itself. Huxley wasn’t really writing about pharmaceuticals, but asking what happens when chemistry replaces the cultivation of virtue and resilience to silence human pain and suffering.
For decades, that question lay in the realm of science fiction. Today, it no longer does. GLP-1s are obviously not soma. They don’t manufacture happiness, and for millions of Americans struggling with obesity and diabetes, they are genuinely life-changing medicines that reduce suffering and save lives. But Huxley understood something that neuroscience is only beginning to explain: that changing desire can actually change behavior.
For too long, our politics has framed obesity as a choice on one side and a disease on the other. The truth, as it often is, is more complicated. Those who argue that discipline, responsibility, and self-control matter are correct. But biology matters too. Anyone who has treated obesity understands that hunger and reward are not simply matters of willpower. If you’ve ever wanted to snack more or binge after an all-nighter, then you know biology can make good choices dramatically harder.
That is why we should resist both extremes. One extreme dismisses GLP-1s as another “miracle cure” sold by Big Pharma. The other imagines that a weekly injection can replace the hard work of building health. Both are false gods.
America’s chronic disease epidemic did not emerge because millions of people simultaneously lost their moral compass. It emerged because we’ve spent generations constructing a nutritional ecosystem that funnels the average American toward metabolic disease, and no injection can solve that problem on its own.
Disease begins with what we eat, how we sleep, how we move, and a food environment that has been, for decades, making processed calories cheaper, more addictive, and more accessible than real nutrition. The Make America Healthy Again (MAHA) movement is rightly focused on those upstream causes. GLP-1s should complement that mission, not compete with it.
Patients taking GLP-1s still need resistance training, adequate protein, better nutrition, better sleep, and sustainable lifestyle changes. Without those foundations, weight loss can come at the expense of strength, resilience, and long-term health. A GLP-1 can make healthier choices easier, but it can’t make them unnecessary.
✍️ Feature
Daily Wire: ‘Big Woe’ Wants You To Believe the American Dream Is Dead
🌍 Foreign
Daily Wire: America Must Abandon Incremental War to Defeat the IRGC
Wall Street Journal: Israel Believes Iran Moved Nuclear Centrifuges Into Pickaxe Mountain
Axios: Iran War Ceasefire Proposal Emerges as Trump Weighs Troops
Telegraph: White House ‘Deeply Concerned’ About Miliband as Foreign Secretary
Telegraph: Trump Expects Burnham to Let America Use UK Bases Against Iran
National Interest: What Elbridge Colby Gets Wrong About the Middle Powers
National Interest: Why Conservative Doubts on Taiwan Are Growing — and Wrong
Jerusalem Post: Opinion: Israel Must Not Lose the Moral Argument
🏛️ Domestic
Fox News: Suspect Named in New York City Alleged Incendiary Device Attack Targeting Anti-ICE Group
Daily Wire: What Explains the Seismic Democratic Shift on Israel?
Wall Street Journal: IRS Commissioner’s Alleged Spying on JPMorgan
Daily Wire: GOP Congresswoman Denies She Helped MAGA Influencer With Insider Trading
New York Post: Treasury Stopped Nearly $100 Million in Taxpayer Money From Going to Dead People
Washington Examiner: Mamdani Testing Limits of Influence With Foreign Policy Forays
New York Post: Mamdani’s Working-Class Costume Is Falling Apart
Daily Wire: The Coco Chanel Commies Making ‘Radical Chic’ Look Quaint
🗳️ 2026
Washington Examiner: Mike Collins’ Controversies Shape Georgia Senate Race
Daily Wire: We Can’t Let China (Or Anyone Else) Invade Our Elections
📰 Media
New York Times: How AI Influencers Are Selling Health Supplements in Fake Ads
Hollywood Reporter: Hunter Biden’s Image Rehab Tour: Nick Fuentes
Daily Wire: Conservatives Take Bill Maher Seriously — Do Democrats?
💻 Tech
Wall Street Journal: Top American AI Executives Sound Alarm on Chinese Models
Semafor: Tech Stocks Rebound After AI Bubble Fear-Induced Slump
🧬 Health
🎭 Culture & Hollywood
Daily Wire: How a Pokémon Card Fight Became My First Lesson in Freedom
Daily Wire: Sometimes We Just Can’t Have Nice Things — Including Zendaya’s Earrings
🪶 Quote
“You do have to feel for all those young, working class New Yorkers making $250k a year who still can’t afford the basic dignities of life: an Equinox membership, daily Sweetgreen, an Oura Ring, the occasional Hillstone Resy, a Taskrabbit housekeeper every now and then, a one-bedroom in a West Village doorman building with in-unit washer/dryer, or—God forbid—a Blade out to the Hamptons sharehouse once a summer.”
— Jesse Arm, in response to Mayor Mamdani


